10.1 Intradialytic Hypotension & Muscle Cramping

Recognize Intradialytic Instability

Intradialytic hypotension (IDH) is a fall in blood pressure during dialysis that can compromise perfusion. Definitions differ across studies and guidelines. Older KDOQI teaching uses a systolic fall of at least 20 mmHg or a mean-pressure fall of at least 10 mmHg with symptoms. These numbers do not establish a universal CMS rule or permission to ignore a symptomatic patient whose fall is smaller. Compare the actual pressure, baseline, symptoms and treatment course.

Early clues include nausea, yawning, pallor, sweating, dizziness, cramping or altered responsiveness. Severe episodes can produce syncope, chest discomfort or arrhythmia. A new complaint warrants assessment rather than reassurance that the patient often feels this way. Repeat a questionable measurement promptly, but do not delay protective action when the patient is obviously unstable. An unremarkable machine screen cannot exclude a clinical emergency.

Why Removal Can Exceed Tolerance

Ultrafiltration removes plasma water, while fluid refills the vascular space from other compartments. Tolerance depends on that refill, vascular tone, cardiac function, autonomic response and the current volume distribution. Edema can coexist with poor intravascular filling. Low albumin, cardiac disease, infection, medications and diabetic autonomic dysfunction can reduce the response to removal. A fixed refill-rate assumption cannot predict safety for every patient.

A high UF rate can increase risk, but no threshold guarantees tolerance. The often-discussed 13 mL/kg/hour value is an observational risk marker, not a mandatory safe ceiling or current universal QIP reporting rule. A patient may become symptomatic below it. Review both volume and treatment time: removing 3,000 mL over four hours at 75 kg is 10 mL/kg/hour, while doing so over three hours is about 13.3. Neither calculation replaces examination or an individualized order.

Repeated instability can compromise myocardial, cerebral and residual kidney perfusion and threaten access patency. Record recurrent symptoms even when they resolve after a brief intervention. The team needs the timing, UF delivered, pressure trend, medicine exposure and response to decide whether the prescription or target weight should change. Finishing treatment does not erase the episode.

Immediate Nursing Response

1. Assess responsiveness, airway, breathing, circulation and the access; call for help when severity warrants.
2. Pause UF through the trained emergency protocol to stop additional fluid removal.
3. Position safely, commonly recumbent with legs elevated when tolerated. A head-down tilt is not mandatory and can worsen breathing in some patients.
4. Give prescribed isotonic saline when indicated, reassessing pressure, symptoms and breathing after each intervention. Do not give a fixed large volume to every hypotensive patient.
5. Confirm blood-pump changes with the emergency procedure or clinician. Routine reduction to a fixed flow is not a reliable treatment for hypotension and can reduce clearance.
6. Notify the responsible clinician promptly and escalate persistent or severe instability to emergency care.

Consider alternatives to simple volume depletion: blood loss, sepsis, arrhythmia, myocardial ischemia, anaphylaxis, air embolism or tamponade. Inspect the access for disconnection and bleeding rather than focusing only on UF. A patient with acute dyspnea and shock needs a broader emergency assessment, and an arbitrary saline-volume threshold must not delay escalation. Oxygen and resuscitation follow the patient's condition and trained protocol.

Preventive Review

Cooler dialysate may reduce thermal stress and support vascular tone, but temperature is prescribed and device-dependent. Monitor discomfort and shivering; cooling is not symptom-free for everyone. Sodium profiling can improve short-term tolerance but may create positive sodium balance, thirst, hypertension and larger future gains. Use it only under an individualized plan.

Midodrine is sometimes prescribed for recurrent IDH. It is not an automatic first-line order for every patient, and evidence and adverse effects require clinical review. The nurse checks the actual dose and timing, monitors pressure and reports concerns. Decisions about holding BP medicines consider hypertension between sessions, indication, dialyzability and prior instability rather than a blanket instruction to stop all agents.

Muscle Cramping and Reassessment

Cramping often accompanies volume shifts or impaired muscle perfusion. Pause UF when clinically indicated, assess pressure and other symptoms, and use gentle stretching under the trained procedure. Prescribed saline may be appropriate when depletion contributes. Do not assume every leg pain is a benign cramp: persistent focal pain, coldness, swelling or neurologic changes require assessment for another cause.

Quinine is not approved for leg-cramp treatment and has serious hematologic and cardiac risks. Do not use it as routine dialysis cramp therapy. Hypertonic saline or dextrose requires a specific order and monitoring; it is not a harmless substitute for reassessing the fluid plan. After improvement, reassess whether treatment can safely resume and document the final delivered UF, fluid administered and clinical response. The future plan should address the cause rather than repeatedly treating symptoms without review.

Sources checked 2026-10-11: UK Kidney Association hemodialysis guideline, CMS QIP technical specifications and FDA quinine safety communication.